Although the difference in viability of around 10% does not explain the enhanced resistance of ECE1cK6R cells to TMZ or GEM, this observation is consistent with the fact that ECE1 inhibition decreases proliferation, as already described for GBM cells [35]. Here, ECE1 is linked to glioblastoma.